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Objectives: To assess trends over a decade in utiliza-
tion of Inferior Vena Cava (IVC) ﬁlters in the U.S by indi-
cation, hospital and patient demographics.
Methods: Retrospective cross-sectional study utilizing
the Nationwide Inpatient Sample Database, 2000-2009.
IVC ﬁlter placement was identiﬁed with ICD-9 codes.
Survey-weighting, bivariate and multivariate analysis was
performed.
Results: The number of IVC ﬁlters placed in the US
increased by 234% over a decade, from 56,380 in 2000
to 132,049 in 2009 (Fig). 84.7% of patients had a PE
or DVT. 94.6% of IVC ﬁlters were placed in urban
hospitals. The largest number of IVC ﬁlters was placed
in the South, followed by the Northeast, Midwest, and
Western regions (38.7%, 25.8%, 22.4%, and 13%, respec-
tively). Adjusting for other patient and hospital factors,
independent predictors of IVC ﬁlter placement were
year, hospital size, location, teaching status, patient age
group 50-79 years, insurance status, and urgency of
admission.
Conclusions: The use of IVC ﬁlters has dramatically
increased over the last decade in the USA, with the
largest utilization of ﬁlters among patients aged 50-79
years, Medicare recipients and the Southern region of
the US. The majority of patients receiving IVC ﬁlters
have an appropriate indication (PE or DVT). Future
studies are required to understand differences inFig.utilization and to optimize selection of patients for IVC
ﬁlter placement.
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Objectives: This study aims to retrospectively validate
a VTE risk score, and compare with physician entered
scores in a previously unstudied high risk cohort: the criti-
cally ill.
Methods: VTE risk factors from the ACCP guide-
lines via Caprini risk scoring and events were identi-
ﬁed for 4,856 patients admitted to our Surgical
Intensive Care Unit from 2007 to 2012, of which
the majority had both clinician-entered VTE and
retrospectively calculated scores. Logistic regression
was used to calculate odds ratio for each level of
VTE risk.
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increased with risk level: 0% in low risk patients, 3.5%
in moderate risk patients, 5.5% in high risk patients
and 8.3% in highest risk group. The difference between
highest and high risk patients was statistically signiﬁcant
(P ¼ .005). Incidence of acquired VTE accelerated in
the highest risk group according to cumulative risk
score, which was signiﬁcant in the 7-8 (8.4%; P ¼
.0217) and 8+ (11.5%; P ¼ .0015) cohorts. The four
risk levels were signiﬁcantly associated with development
of VTE during hospitalization. Clinician-entered scores
were within 1 point of the retrospectively calculated
score in 74% of cases. However, in 26% of cases there
was signiﬁcant disagreement by $2 points between the
scores. The clinician-entered score signiﬁcantly underes-
timated risk in 80% of these cases. In patients misclassi-
ﬁed from the highest risk group downwards, the risk of
VTE was higher (P ¼ .0007) than the physician score
predicted.
Conclusions: The VTE risk assessment score is valid
in the critically ill and supports the use of individualized
risk assessment upon admittance to the ICU.
Clinician entered scores signiﬁcantly diverge from
retrospectively calculated scores in one quarter of cases
and result in poor discrimination of VTE risk. Discrep-
ancies were usually the result of under-scoring.
The impact of misclassiﬁcation on thromboprophylaxis
prescribing regimen and incidence of VTE requires further
study.
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Objectives: The CEAP classiﬁcation (Clinical-
Etiology-Anatomy-Pathophysiology) is the golden stan-
dard for classiﬁcation of chronic venous disease (CVD)
today and is often used as part of local guidelines when
selecting patients for treatment within the national health-
care system. Many clinicians ﬁnd both CEAP and local
guidelines difﬁcult to apply in clinical reality, and patients
often seek a second opinion if they disagree with the exam-
ining doctor. The aim of this study was to evaluate the
reproducibility of the clinical class of CEAP when used in
a clinical situation where the decision for reimbursement
of treatment was made.
Methods: At a high-volume center in Stockholm,
an unselected series of 78 patients (106 limbs) withvaricose veins or CVD were examined by three inde-
pendent surgeons with regard to CEAP “C”. It was
also determined whether there was a medical indication
for treatment according to the local guidelines,
which would allow for treatment to be funded by
the Stockholm County. Pairwise comparison with
simple kappa was used to investigate the inter-observer
reproducibility.
Results: The simple kappa for “C” between all
observers was 0.55-0.68 (95% CI), where least agreement
was noted in class C3. Medical indication had a simple
kappa of 0.35-0.57 (95% CI).
Conclusions: There was a considerable discrepancy
between the surgeons assessing the clinical class of CVD
and even more so when deciding the medical indication
for treatment. This may be due to inherent difﬁculties in
the CEAP, lack of speciﬁc training, or the simultaneous
assessment of reimbursement that may inﬂuence the
grading of clinical class.
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Objectives: Differences in access to vascular care
remain unexplained for patients with lower extremity
PAD. We studied relationships between the quality of
medical care for patients with PAD and access to vascular
care.
Methods: We identiﬁed a cohort of 52,505 Medi-
care patients with pre-existing diabetes, PAD, and
foot ulceration who required hospitalization for foot
cellulitis. Across regions in the Dartmouth Atlas, we
determined the proportion of patients that received
appropriate, high quality medical care, deﬁned as (1)
hemoglobin A1C testing, (2) podiatric care, and (3)
non-invasive vascular testing, all within 1 year of
hospital admission. We assessed regional relationships
between quality of medical care and vascular care,
deﬁned as diagnostic/therapeutic vascular care for
CLI patients.
Results: Across the United States, only 36% of dia-
betic patients with PAD and tissue loss received all three
components of high quality medical care; 76% received
2 of 3 components. A non-invasive vascular study was
absent in 41%. Provision of high-quality medical care
varied across regions, from 4% of patients in Mason
City, Iowa to 58% of patients in Sun City, Arizona.
Regions most likely to provide high quality medical care
were 24% more likely to provide invasive vascular care
(P < .001; Fig).
Conclusions: Fewer than 4 out of 10 Medicare dia-
betics with PAD and tissue loss receive appropriate, high
quality medical care. Quality improvement efforts at
